lobbying_filings_raw: ed30b2ff-da64-4745-bf92-e39d11dc7b21
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ed30b2ff-da64-4745-bf92-e39d11dc7b21 | Q3 | 320918 | KOUNTOUPES DENHAM CARR & REID, LLC | 186710 | GLENMARK PHARMACEUTICALS, INC., USA | 2020 | third_quarter | 2020-10-14T13:06:35.537000-04:00 | 50000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/ed30b2ff-da64-4745-bf92-e39d11dc7b21/", "filing_uuid": "ed30b2ff-da64-4745-bf92-e39d11dc7b21", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2020, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/ed30b2ff-da64-4745-bf92-e39d11dc7b21/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Paula M. Short", "dt_posted": "2020-10-14T13:06:35.537000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "607 - 14th Street NW", "registrant_address_2": "Suite 750", "registrant_different_address": true, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 320918, "url": "https://lda.senate.gov/api/v1/registrants/320918/", "house_registrant_id": 39554, "name": "KOUNTOUPES DENHAM CARR & REID, LLC", "description": "Federal lobbying and consulting services", "address_1": "607 - 14th Street NW", "address_2": "Suite 750", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "PAULA M. SHORT", "contact_telephone": "+1 202-803-4585", "dt_updated": "2026-01-28T11:54:35.576641-05:00"}, "client": {"id": 186710, "url": "https://lda.senate.gov/api/v1/clients/186710/", "client_id": 1005305, "name": "GLENMARK PHARMACEUTICALS, INC., USA", "general_description": "Leading,integrated, research-driven, global pharmaceutical manufacturing company.", "client_government_entity": false, "client_self_select": null, "state": "NJ", "state_display": "New Jersey", "country": "US", "country_display": "United States of America", "ppb_state": "NJ", "ppb_state_display": "New Jersey", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-04-01"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.", "foreign_entity_issues": "Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.", "lobbyists": [{"lobbyist": {"id": 70770, "prefix": null, "prefix_display": null, "first_name": "MJ", "nickname": null, "middle_name": null, "last_name": "KENNY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 72966, "prefix": null, "prefix_display": null, "first_name": "ADAM", "nickname": null, "middle_name": null, "last_name": "HECHAVARRIA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 142331, "prefix": null, "prefix_display": null, "first_name": "LISA", "nickname": null, "middle_name": null, "last_name": "KOUNTOUPES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "General education about the generic pharmaceutical industry.", "foreign_entity_issues": "Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.", "lobbyists": [{"lobbyist": {"id": 59326, "prefix": "ms", "prefix_display": "MS.", "first_name": "MARY", "nickname": null, "middle_name": "R \"RANDI\"", "last_name": "REID", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 70770, "prefix": null, "prefix_display": null, "first_name": "MJ", "nickname": null, "middle_name": null, "last_name": "KENNY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 72966, "prefix": null, "prefix_display": null, "first_name": "ADAM", "nickname": null, "middle_name": null, "last_name": "HECHAVARRIA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 142331, "prefix": null, "prefix_display": null, "first_name": "LISA", "nickname": null, "middle_name": null, "last_name": "KOUNTOUPES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. \nS. Amdt 2652, the Targeted COVID Relief Package. Issues related to the federal response to the COVID-19 pandemic. Supply chain and essential medicine manufacturing.", "foreign_entity_issues": "Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.", "lobbyists": [{"lobbyist": {"id": 59326, "prefix": "ms", "prefix_display": "MS.", "first_name": "MARY", "nickname": null, "middle_name": "R \"RANDI\"", "last_name": "REID", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 70770, "prefix": null, "prefix_display": null, "first_name": "MJ", "nickname": null, "middle_name": null, "last_name": "KENNY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 72966, "prefix": null, "prefix_display": null, "first_name": "ADAM", "nickname": null, "middle_name": null, "last_name": "HECHAVARRIA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 142331, "prefix": null, "prefix_display": null, "first_name": "LISA", "nickname": null, "middle_name": null, "last_name": "KOUNTOUPES", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 11, "name": "Executive Office of the President (EOP)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |